U.S. Food Stock News

Capricor Therapeutics recently presented Phase 3 HOPE-3 data for its Duchenne muscular dystrophy therapy Deramiocel at the 2026 American Academy of Neurology meeting, highlighting preserved function and slower disease progression, including real-world self-feeding outcomes captured via the Duchenne Video Assessment. The company emphasized that these clinical results, combined with Deramiocel’s multiple regulatory designations and an ongoing FDA Biologics License Application review with an...

Gartner (NYSE:IT) now expects global IT spending to reach US$6.31t in 2026. The new forecast highlights rapid growth in AI infrastructure and services as a key driver. The outlook points to rising enterprise budgets tied directly to AI adoption and deployment. For investors watching Gartner, this forecast speaks directly to the core of its research and advisory business. The company operates at the intersection of technology buyers and vendors, and its updated view on IT spending reflects...

In the first quarter of 2026, Carillon Tower Advisers highlighted XPO, Inc.’s strong less‑than‑truckload performance and improved service levels, even as freight conditions remained difficult. This recognition underscored how XPO’s operational execution is helping narrow its service and pricing gap with a leading peer, which may influence how investors view its longer-term prospects. Next, we’ll examine how this operational improvement spotlight fits with XPO’s existing investment narrative...

Fabrinet recently released its fiscal 2026 third-quarter results and held a conference call, with a replay now available on the company’s website. Investor attention has intensified as Fabrinet’s history of exceeding earnings estimates and current positive indicators suggest the market is closely watching its earnings execution. With Fabrinet’s earnings release now out and expectations shaped by its track record of positive surprises, we’ll examine how this affects the investment...

Global rates, energy prices and mixed inflation data are keeping markets on edge, yet they are also shining a light on companies where leadership is deeply invested in long term outcomes. Founder led businesses often have more skin in the game, tighter capital discipline and clear decision making when conditions are choppy. This is exactly what the Top Founder Led Companies screener is built to highlight, focusing on capital efficiency and ownership. In this article, you will see 3 of the...

CME Group (CME) opened 2026 with Q1 revenue of US$1.9b and basic EPS of US$3.25, setting the tone for another data rich update for shareholders. The company has seen quarterly revenue move from US$1.6b in Q1 2025 to US$1.9b in Q1 2026, while basic EPS has shifted from US$2.63 to US$3.25 over the same period, against a backdrop of trailing 12 month earnings growth of 18.5%. For investors, the combination of higher trailing net margins and these headline figures puts the focus firmly on how...

Why Keysight Technologies (KEYS) is on investors’ radar Keysight Technologies (KEYS) has drawn attention after a strong run over the past month and past 3 months, with the stock’s returns outpacing its recent 1 day move. See our latest analysis for Keysight Technologies. At a latest share price of $338.97, Keysight’s recent 30 day share price return of 17.31% and 90 day share price return of 57.13% sit alongside a 1 year total shareholder return of 146.90%. Together, these figures point to...

Marsh & McLennan Companies (MRSH) reported first quarter 2026 earnings with sales of US$7.6b and net income of US$1.1b, a combination of higher revenue and lower profitability that can influence stock sentiment. See our latest analysis for Marsh & McLennan Companies. The earnings update, leadership changes and ongoing buyback have come during a softer patch for the stock, with a 1-year total shareholder return of an 18.34% decline and a 5-year total shareholder return of 41.31%. This suggests...

First BanCorp (FBP) opened 2026 with Q1 revenue of US$241.4 million and basic EPS of US$0.57, alongside trailing 12 month revenue of US$932.9 million and EPS of US$2.26 that frame the latest quarterly print in a broader earnings run rate. Over the past year, the bank has seen revenue move from US$876.8 million to US$932.9 million on a trailing basis while EPS shifted from US$1.82 to US$2.26, giving a clearer read on how the top and bottom lines have been tracking into this quarter. With a...

Grupo Aeroméxico. de (NYSE:AERO) has opened 2026 with Q1 revenue of US$1.3 billion and basic EPS of US$0.08, alongside trailing twelve month revenue of US$5.5 billion and EPS of US$2.34 that frame the latest quarter in a broader earnings context. The company has seen quarterly revenue move from US$1.18 billion in Q1 2025 to US$1.44 billion in Q4 2025 before landing at US$1.34 billion in Q1 2026, while basic EPS has ranged from US$0.16 to US$0.97 over the past year. This sets up a results...

If you are wondering whether Lyft at around US$14.44 offers fair value or a margin of safety, this article walks through what the current price might be indicating. The stock has had mixed returns, with a 1.5% decline over the last 7 days, an 8.2% gain over the last 30 days, a 27.0% decline year to date, and a 26.2% return over the past year. This can indicate that the market is still adjusting its view on risk and potential. Recent headlines around Lyft have focused on its position in the...

In April 2026, Synchrony announced the launch of the RH Credit Card, a financing solution for RH customers that offers promotional financing across RH Galleries, Outlets, and RH.com, fully integrated into the RH Members Program with streamlined digital prequalification and application. An interesting angle is RH’s access to Synchrony’s PRISM decisioning system, which uses thousands of data points to support more tailored and responsible credit offerings for its clientele. We’ll now examine...

If you are wondering whether LyondellBasell Industries is priced fairly or if the current share price leaves some value on the table, this article walks through the key clues in plain language. At a last close of US$72.00, the stock has returned 62.2% year to date and 36.2% over the past year. The 7 day and 30 day returns of a 1.5% decline and a 0.7% gain hint at shifting short term sentiment. Recent coverage has focused on how LyondellBasell fits into the broader chemicals space, including...

If you are wondering whether Comstock Resources at US$17.44 is genuinely good value or just looks cheap on the surface, the key is to understand how its current price compares with different valuation measures. The stock has recently shown mixed returns, with a 7.2% gain over the last week, a 17.7% decline over the last month, and returns of 26.0% decline year to date and 5.6% decline over the last year, set against a 69.7% return over three years and a 238.2% return over five years. Recent...

Costco Wholesale (COST) has approved an increase of more than 13% in its quarterly cash dividend to $1.47 per share, placing a stronger emphasis on shareholder returns as the stock trades near $1,003.70. See our latest analysis for Costco Wholesale. The higher dividend comes as the latest 7 day share price return of 1.92% and year to date share price return of 17.46% contrast with a more modest 1 year total shareholder return of 3.42%. At the same time, 3 and 5 year total shareholder returns...

Westinghouse Air Brake Technologies (WAB) opened 2026 with Q1 revenue of US$2.95b and basic EPS of US$2.13, setting the tone for how the year is starting to shape up after a period of steady earnings expansion. The company has seen revenue move from US$2.61b in Q1 2025 to US$2.95b in Q1 2026, while basic EPS over that span ranged from US$1.88 in Q1 2025 to US$2.13 in the latest quarter. Trailing twelve month EPS reached US$7.08 as net income for that period came in at US$1.21b. With earnings...

Wondering if Allstate at around US$214 per share still offers value, or if most of the opportunity has already been priced in? This article walks through that question step by step so you can judge the stock's valuation with more confidence. Over the last week the stock has recorded a 1.9% decline, while the 1 year return sits at 12.1% and the 3 year return is 101.0%. That kind of mix can leave investors unsure whether the current price signals fresh potential or a change in risk...

Q1 2026, Boston Scientific (NYSE:BSX) reported positive clinical trial results for the WATCHMAN FLX Left Atrial Appendage Closure Device and the EKOS Endovascular System. The company completed its acquisition of Valencia Technologies Corporation during the quarter. Boston Scientific also received regulatory approvals for the OPAL HDx Mapping System and the Asurys Fluid Management System. Boston Scientific is a large medical device company focused on cardiovascular, endovascular, and other...

GE Vernova (GEV) has opened 2026 with Q1 total revenue of US$9.3 billion and basic EPS of US$17.64 on net income of US$4.7 billion, setting a clear marker for its latest earnings season update. The company has seen quarterly revenue move from US$8.0 billion in Q1 2025 to US$9.3 billion in Q1 2026, while basic EPS stepped up from US$0.92 to US$17.64 over the same period, alongside trailing 12 month EPS of US$34.66 and net income of US$9.4 billion. With revenue growth forecasts above the wider...

Recently, Upstart Holdings disclosed a forward-flow commitment under which funds managed by Centerbridge Partners will buy up to US$1.2 billion of consumer loans originated on its AI-driven lending platform over 24 months, expanding funding access for products ranging from unsecured personal credit to auto and home equity lines. This large, multi-year loan purchase agreement highlights how institutional investors are committing sizable capital directly to Upstart’s model-driven underwriting,...

Earlier in April 2026, Morningstar said it is revisiting its index design rules to more quickly incorporate unusually large IPOs such as SpaceX, including by introducing an alternative liquidity screen to accelerate benchmark inclusion. This potential shift in index construction could materially influence how asset managers track Morningstar benchmarks, adjust portfolio exposures, and respond to future mega-IPOs. With Morningstar’s revised liquidity screen for giant IPOs under consideration,...

Douglas Dynamics (PLOW) is back on investor radars after recent share price moves, with the stock showing gains over the past month and past 3 months that stand out compared with its longer term record. See our latest analysis for Douglas Dynamics. The recent share price return of 10.5% over 30 days and 21.6% over 90 days, alongside a 38.6% year to date share price return and 101.1% 1 year total shareholder return, points to strong momentum building around Douglas Dynamics at a last close of...

Wondering if HealthEquity at around US$82.88 is priced for its future potential or already reflects the story you are buying into today? This article focuses squarely on what you are getting for the price you pay. The stock has delivered a 54.0% return over 3 years, while the 1 year return sits at a 3.7% decline and the year to date move is a 9.0% decline, which may have shifted how investors are thinking about both upside and risk. Recent coverage has focused on HealthEquity's role in US...

Market context for Lindblad Expeditions Holdings (LIND) Lindblad Expeditions Holdings (LIND) has drawn investor attention after recent share price moves, with the stock showing mixed short term performance while posting stronger total returns over the past year and past 3 months. The company, which runs marine expedition adventures and land based travel experiences, now carries a market value of about US$1.22b and last closed at US$18.33. This has prompted closer scrutiny of its current...